Search - tctmd.com

Displaying 421 - 440 of 488

Sort: Relevancy | Date

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Daily News

TEVAR Alleviates Racial Disparity for Thoracic Aneurysm Repair

L.A. McKeown

December 16, 2012

News Daily News

La TEVAR Alivia la Disparidad Racial en la Reparación del Aneurisma Torácico

L.A. McKeown

December 16, 2012

Presentation

Thoracic Endovascular Aneurysm Repair, Race, and Volume in Thoracic Aneurysm Repair

Presenter: Philip P. Goodney

December 13, 2012

News Industry News

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

November 15, 2012

News Industry News

FDA Approves Medtronic Stent Graft for Aortic Transection Repair

November 12, 2012

News Conference News TCT 2012

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

October 31, 2012

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

Presentation TCT 2012

Thoracic Aortic Repair in the Endovascular Era: Current and Future Perspectives

Presenter: Edward Diethrich

October 25, 2012

Presentation TCT 2012

Case 4: Thoracic Aortic Dissection During Aortic Valve Implantation

Presenter: Ajay Sinhal

October 25, 2012

News Conference News TCT 2012

Registries Show TAVR Evolution in UK, Internationally

October 24, 2012

Presentation TCT 2012

TCT-3. Early Results of Multicenter, Prospective Trial of TEVAR for Blunt Thoracic Aortic Injury (RESCUE Trial)

Presenter: Ali Khoynezhad

October 23, 2012

Presentation TCT 2012

Debate: Do the Data Support Endovascular Therapy for Descending Thoracic Aortic Dissections? Con!

Presenter: Christoph Nienaber

October 22, 2012

Presentation TCT 2012

Case 4: Percutaneous Repair of Thoracic Aortic Aneurysms

Presenter: Sergey Abugov

October 22, 2012

Presentation TCT 2012

Debate: Do the Data Support Endovascular Therapy for Descending Thoracic Aortic Dissections? Pro!

Presenter: Eric Roselli

October 22, 2012

News Industry News

FDA expands approved use of Sapien artificial heart valve

October 19, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

October 10, 2012

News Daily News

Frailty Index Best at Predicting Functional Decline After TAVR

Yael L. Maxwell

September 28, 2012

News Daily News

Frailty Score Predicts 1-Year Mortality But Not Procedural Complications in TAVR

September 18, 2012

Advertisement

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

TEVAR Alleviates Racial Disparity for Thoracic Aneurysm Repair

La TEVAR Alivia la Disparidad Racial en la Reparación del Aneurisma Torácico

Thoracic Endovascular Aneurysm Repair, Race, and Volume in Thoracic Aneurysm Repair

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

FDA Approves Medtronic Stent Graft for Aortic Transection Repair

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Thoracic Aortic Repair in the Endovascular Era: Current and Future Perspectives

Case 4: Thoracic Aortic Dissection During Aortic Valve Implantation

Registries Show TAVR Evolution in UK, Internationally

TCT-3. Early Results of Multicenter, Prospective Trial of TEVAR for Blunt Thoracic Aortic Injury (RESCUE Trial)

Debate: Do the Data Support Endovascular Therapy for Descending Thoracic Aortic Dissections? Con!

Case 4: Percutaneous Repair of Thoracic Aortic Aneurysms

Debate: Do the Data Support Endovascular Therapy for Descending Thoracic Aortic Dissections? Pro!

FDA expands approved use of Sapien artificial heart valve

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

Frailty Index Best at Predicting Functional Decline After TAVR

Frailty Score Predicts 1-Year Mortality But Not Procedural Complications in TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content